Skip to main content
Tech.euFundingExplorerBeta

Libera Bio

Biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer.

Libera Bio has raised €1.6M across 2 funding rounds from 7 investors, most recently a Seed round in Jul 2022. Based in A Coruña, Spain; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.6M
€1,590,000
Funding rounds
2
Investors
7
distinct backers
Active since
2022-01
latest 2022-07

Funding by year

EUR raised per year
Libera Bio — funding by year — interactive chart.
Data table
Libera Bio — funding by year
2022€1.6M

Signals

High confidence
Raise-next likelihood9
base rate 44% for Seed
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData